NCT07921719Not yet recruiting
PROMETHEE: A Shared Interregional Tele-Tobacco Cessation Platform Embedded Within the IMPULSION Lung Cancer Screening Program
Evaluation of an Intensive Tele-Tobacco Cessation Program Compared With Standard Smoking Cessation Support in Participants of the French IMPULSION Lung Cancer Screening Program (PROMETHEE)
Source: ClinicalTrials.gov · Last updated 6 Nov 2026
Brief summary (registry, in English)
This prospective observational study aims to evaluate whether an intensive tele-tobacco cessation program delivered through the PROMETHEE platform improves smoking cessation among smokers participating in the French national lung cancer screening pilot program IMPULSION. Participants receiving the PROMETHEE pathway will be compared with matched controls receiving standard smoking cessation support available through IMPULSION. The primary endpoint is self-reported smoking cessation at 12 months.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 5400 (estimated)
- First submitted
- 27 Oct 2026
- Start date
- Jan 2027
- Primary completion date
- Jan 2030
- Lead sponsor
- Hospices Civils de Lyon
- Diseases
- Lung cancer
- NCT number
- NCT07921719
What you commit to
- Study type: Observational
- Planned participants: 5400
- From Jan 2027 to the primary completion date, Jan 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Control subjects already included in PROMETHEE
- Any exclusion criterion applicable under the IMPULSION program itself
Who the study is looking for
- PROMETHEE Group:
- Enrolled in IMPULSION
- Active smoker or smoking cessation within the previous month
- Referred to PROMETHEE by an IMPULSION investigator
- Control Group:
- Enrolled in IMPULSION
- Active smoker or smoking cessation within the previous month
- Not referred to PROMETHEE
- Selected from the IMPULSION database
- Matched by age (±5 years) and sex
Age in the registry: 50 years to 74 years · Sex: All
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Service de Pneumologie Aigue Spécialisée et Cancérologie Thoracique, Hôpital Lyon Sud, Hospices Civils de Lyon | Pierre-Bénite | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.